| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CB | Common Shares | Options Exercise | $2,924,480 | +25,479 | +18% | $114.78 | 165,401 | 19 Mar 2024 | Direct | F1 |
| transaction | CB | Common Shares | Sale | $6,075,541 | -23,474 | -14% | $258.82 | 141,927 | 19 Mar 2024 | Direct | F1, F2 |
| transaction | CB | Common Shares | Sale | $520,277 | -2,005 | -1.4% | $259.49 | 139,922 | 19 Mar 2024 | Direct | F1, F3 |
| transaction | CB | Common Shares | Sale | $1,032,923 | -3,998 | -2.9% | $258.36 | 135,924 | 19 Mar 2024 | Direct | F4 |
| transaction | CB | Common Shares | Sale | $1,294,825 | -4,987 | -3.7% | $259.64 | 130,937 | 19 Mar 2024 | Direct | F5 |
| holding | CB | Common Shares | 78,700 | 19 Mar 2024 | By Trust for Wife | ||||||
| holding | CB | Common Shares | 10,000 | 19 Mar 2024 | By Trust for Descendants |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CB | Options to Acquire Common Shares | Options Exercise | $0 | -25,479 | -13% | $0.000000 | 167,150 | 19 Mar 2024 | Common Shares | 25,479 | $114.78 | Direct | F1, F6, F7 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | These options were exercised and the resulting shares were sold in compliance with a qualified selling plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
| F2 | The Common Shares reported herein as being sold were sold at a range of between $258.40 and $259.40 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range. |
| F3 | The Common Shares reported herein as being sold were sold at a range of between $259.41 and $259.69 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range. |
| F4 | The Common Shares reported herein as being sold were sold at a range of between $258.21 and $258.41 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range. |
| F5 | The Common Shares reported herein as being sold were sold at a range of between $259.425 and $259.520 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range. |
| F6 | The options vested in equal installments on February 26, 2016, February 26, 2017 and February 26, 2018. |
| F7 | There are 871 options remaining in this tranche. Total includes options from other tranches with different exercise prices, vesting and expiration dates. |
*and President, North America Insurance